Pfizer's drug pricing deal with Trump ratchets up pressure on other pharma companies - Axios
Axios
*PFIZER GETS THREE-YEAR GRACE PERIOD FROM TRUMP PHARMA TARIFFS
*TRUMP: PFIZER AGREED TO OFFER MEDICATIONS AT MAJOR DISCOUNTS
*TRUMP: WE'RE GOING TO BE PAYING THE LOWEST PRICE
*TRUMP: US WILL BE PAYING MOST FAVORED NATIONS PRICE
$PFE 🇺🇸🇺🇸 https://t.co/8M1pqstQqU
@Investingcom
Pfizer found a way to boost its ailing stock — agree with Trump on drug pricing
MarketWatch
*PFIZER CEO BOURLA EXPECTED TO ANNOUNCE A $70 BILLION INVESTMENT ON MANUFACTURING MEDICATIONS IN THE UNITED STATES - WSJ
$PFE https://t.co/cugdq5PhfT
@Investingcom
*TRUMP, PFIZER TO ANNOUNCE AGREEMENT TO LOWER DRUG PRICES https://t.co/CfoQxH0KEf
@Investingcom
Key deals this week: STAAR Surgical, Pfizer, DB Insurance, Strive, Rocket Lab and more
Seeking Alpha
4 stocks to watch on Monday: PFE, KO, STLA, ORCL
SeekingAlpha
Pfizer boosts obesity drug prospects with $7.3 billion deal to buy Metsera
CNBC
Pfizer makes a $4.9 billion bet on obesity drugs with Metsera buyout deal
MarketWatch
Pfizer nears $7.3B takeover of weight loss drugmaker Metsera, FT reports
SeekingAlpha
BNB Market Cap Hits $139.01B — Surpasses ExxonMobil, BYD and Pfizer to Rank 156th Globally
CoinOtag
Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
CNBC
Pfizer collaboration with Olema may spark future bidding war - analyst
SeekingAlpha
Pfizer boosts profit estimate, even as tariffs are absorbed and drug prices may be cut
MarketWatch
Pfizer makes a $6 billion run into a new cancer drug race, 6 months after rival
MarketWatch
Pfizer faces investment roadblock in US due to tariffs uncertainty
Cryptopolitan
Viking among notable gainers as Pfizer raises deal prospects
SeekingAlpha
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
🇺🇸EARNINGS THIS WEEK:
• APPLE $AAPL
• MICROSOFT $MSFT
• AMAZON $AMZN
• META PLATFORMS $META
• QUALCOMM $QCOM
• EXXONMOBIL $XOM
• CHEVRON $CVX
• ELI LILLY $LLY
• PFIZER $PFE
• CVS HEALTH $CVS
• COCA-COLA $KO
• MCDONALD’S $MCD
• STARBUCKS $SBUX
• DOMINO’S PIZZA $DPZ https://t.co/sSgfg33rYW
@Investingcom
Pfizer stock climbs on Q4 revenue and earnings beat, reaffirmed guidance
MarketWatch
🎉ANOTHER BIG EARNINGS WEEK IS UPON US!
💰 $GOOGL $AMZN $AMD $ARM $QCOM $PLTR $SNAP $DIS $PYPL $LLY $PFE $MRK $NVO $UBER $F $RACE $TM $PEP $CMG ARE ALL SET TO DELIVER RESULTS!
📈PLAN EARLY WITH ALL KEY DATA IN 1 PLACE: https://t.co/Zh3sZIRv6K 👈 https://t.co/0Zont0zt9H https://t.co/JTwOtijLxx
@Investingcom
🇺🇸EARNINGS THIS WEEK:
• ALPHABET $GOOGL
• AMAZON $AMZN
• AMD $AMD
• ARM HOLDINGS $ARM
• QUALCOMM $QCOM
• PALANTIR $PLTR
• FORTINET $FTNT
• SNAP $SNAP
• ROBLOX $RBLX
• WALT DISNEY $DIS
• PAYPAL $PYPL
• ELI LILLY $LLY
• PFIZER $PFE
• MERCK $MRK
• NOVO NORDISK $NVO… https://t.co/n8VluKA3Gy https://t.co/NBsP246CAc
@Investingcom
Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends Hemophilia pact
MarketWatch
Pfizer names oncology chief and company veteran Boshoff as chief scientific officer
MarketWatch
Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
MarketWatch
Pfizer CEO says he welcomes good ideas as Starboard ups pressure on company
CNBC
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales - CNBC
CNBC
FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease - CNBC
CNBC
Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment
MarketWatch
Pfizer former executives exit activist drive (NYSE:PFE) - Seeking Alpha
Seeking Alpha
Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says - CNBC
CNBC
Former Pfizer CEO, finance chief step back from Starboard's activist campaign - CNBC
การลงทุนในหุ้นต้องการการวิจัยอย่างละเอียด รวมถึงการวิเคราะห์ข้อมูลทางการเงินของบริษัท ข่าวที่เกี่ยวข้อง และการวิเคราะห์ทางเทคนิค ปัจจุบันคำแนะนำจากนักวิเคราะห์ทางเทคนิคของ Tesla แสดงให้เห็นว่าเป็นการให้คะแนน hold